During the past decade, St. Joseph's Children's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph's Children's Hospital" #1 sponsor was "Genzyme, a Sanofi Company" with 4 trials, followed by "Halozyme Therapeutics" with 1 trials sponsored, "MedImmune LLC" with 1 trials sponsored, "National Center for Research Resources (NCRR)" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph's Children's Hospital" #1 collaborator was "Baxter Healthcare Corporation" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph's Children's Hospital" are "Anemia" (1 trials), "Anemia, Sickle Cell" (1 trials), "Cerebroside Lipidosis Syndrome" (1 trials), "Cerebrovascular Accident" (1 trials) and "Chronic Lung Disease" (1 trials). Many other conditions were trialed in "St. Joseph's Children's Hospital" in a lesser frequency.

Most popular intervention types in "St. Joseph's Children's Hospital" are "Drug" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferasirox" (1 trials), "Hydroxyurea" (1 trials), "Iron Chelation" (1 trials), "Liquid Palivizumab" (1 trials) and "Lyophilized Palivizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph's Children's Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "St. Joseph's Children's Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Joseph's Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph's Children's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".